Ultrafiltration membrane having biological substance adhesion suppressing ability
A coating film on ultrafiltration membranes using ethylene-based polymers and crosslinking groups addresses adhesion issues, enhancing recovery rates and membrane integrity for biological substance separation.
Patent Information
- Application Number
- JP2023075839
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-05-01
- Publication Date
- 2024-11-14
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing ultrafiltration membranes face issues with membrane permeation inhibition and sample loss due to the adhesion of biological substances such as proteins, polysaccharides, and microorganisms, leading to reduced recovery rates.
Applying a coating film containing ethylene-based polymers and crosslinking groups to the ultrafiltration membrane surface to suppress the adhesion of biological substances, enhancing the membrane's ability to prevent permeation inhibition and sample loss.
The coated ultrafiltration membrane effectively reduces adhesion of biological substances, improving recovery rates and maintaining membrane integrity under centrifugal forces, suitable for ultrafiltration using centrifuges.
Smart Images

Figure 2024160625000001 
Figure 2024160625000002 
Figure 2024160625000003
Abstract
Description
[Technical field]
[0001] The present invention relates to an ultrafiltration membrane having a coating membrane capable of inhibiting adhesion of biological materials, a centrifugal ultrafiltration filter unit having the ultrafiltration membrane, and a method for producing the same. [Background technology]
[0002] For the desalting, separation, concentration and / or purification of biological samples, and for the pretreatment of analytical samples, techniques such as microfiltration, ultrafiltration, and reverse osmosis using porous filtration membranes are known. In particular, for the purpose of virus concentration, protein concentration, nucleic acid purification, and the like, ultrafiltration using porous filtration membranes with a nominal molecular weight cutoff (NMWL) of 1 kDa to 1000 kDa, particularly ultrafiltration using a centrifuge, is widely used. In addition, for use in ultrafiltration using a centrifuge, centrifugal ultrafiltration filter units and the like consisting of a two-layer structure of a filter unit equipped with an ultrafiltration membrane and a tube for collecting the filtrate are also commercially available.
[0003] However, porous filtration membranes used for filtering biological samples have problems such as the adsorption of proteins, polysaccharides, microorganisms, and fine particles contained in the biological samples to the filtration membrane, inhibiting their permeation through the membrane, and reducing the recovery rate due to the loss of target sample components (e.g., proteins and viruses) caused by adsorption.
[0004] In order to avoid such problems, hydrophilic materials such as regenerated cellulose are used as the membrane material. Alternatively, surface treatment of hydrophobic membrane materials, for example, adsorption or incorporation of a copolymer (e.g., MPC copolymer) containing a monomer having a phosphorylcholine group as a constituent component on the surface of a porous membrane (see, for example, Patent Documents 1 and 2), and surface modification by introducing a functional polymer into a porous membrane using a crosslinking component (see, for example, Patent Document 3) have been reported. However, no membrane materials or surface treatments thereof that are suitable for use in ultrafiltration and have sufficient biological material adhesion suppression capabilities have been reported. [Prior art documents] [Patent documents]
[0005] [Patent Document 1] JP 2006-239636 A [Patent Document 2] JP 2016-77923 A [Patent Document 3] International Publication No. 2017 / 170210 Summary of the Invention [Problem to be solved by the invention]
[0006] An object of the present invention is to provide an ultrafiltration membrane that is excellent in the ability to inhibit adhesion of biological materials and that is free from problems such as inhibition of membrane permeation and sample loss. [Means for solving the problem]
[0007] As a result of extensive research, the inventors have discovered that by applying a coating membrane capable of inhibiting the adhesion of biological materials to at least a portion of the surface of an ultrafiltration membrane, it is possible to provide an ultrafiltration membrane that has excellent ability to inhibit the adhesion of biological materials and is free of problems such as inhibition of membrane permeation and sample loss, and have thus completed the present invention.
[0008] The present invention is as follows. [1] An ultrafiltration membrane comprising a coating membrane having an ability to inhibit adhesion of biological material on at least a portion of its surface. [2] The ultrafiltration membrane according to [1], wherein the ultrafiltration membrane is a flat membrane. [3] The ultrafiltration membrane according to [1], wherein the ultrafiltration is normal flow filtration. [4] The ultrafiltration membrane described in [1], wherein the biological material is a protein, a sugar, a lipid, a virus, a nucleic acid, a cell, an extracellular vesicle (EV), or a combination thereof. [5] The ultrafiltration membrane according to [1], which is used for separating, purifying and / or concentrating biological materials. [6] The ultrafiltration membrane according to [1], wherein the coating membrane comprises a polymer or a cured product thereof comprising a repeating unit derived from one or more ethylenically unsaturated monomers selected from the group consisting of (meth)acrylic acid and its esters, vinyl acetate, vinylpyrrolidone, ethylene, vinyl alcohol, and hydrophilic functional derivatives thereof. [7] The ultrafiltration membrane according to [6], wherein the coating membrane comprises a cured product of a polymer containing repeating units derived from one or more ethylenically unsaturated monomers selected from the group consisting of (meth)acrylic acid and its esters, vinyl acetate, vinylpyrrolidone, ethylene, vinyl alcohol, and hydrophilic functional derivatives thereof, and the curing proceeds via one or more crosslinking groups selected from the group consisting of azide groups, diazo groups, diazide groups, and carbodiimide groups. [8] A centrifugal ultrafiltration filter unit comprising the ultrafiltration membrane described in [1]. [9] A method for separating, purifying and / or concentrating biological materials using the centrifugal ultrafiltration filter unit described in [8].
[10] A method for producing an ultrafiltration membrane having the ability to inhibit the adhesion of biological material, comprising the steps of applying a coating film-forming composition having the ability to inhibit the adhesion of biological material to at least a portion of the surface of the ultrafiltration membrane, and drying the applied composition.
[11] The method according to
[10] , wherein the composition for forming a coating film contains a polymer including a repeating unit derived from one or more ethylenically unsaturated monomers selected from the group consisting of (meth)acrylic acid and its esters, vinyl acetate, vinylpyrrolidone, ethylene, vinyl alcohol, and hydrophilic functional derivatives thereof.
[12] The method according to
[11] , wherein the composition for forming a coating film contains a crosslinking component containing one or more crosslinking groups selected from the group consisting of an azide group, a diazo group, a diazide group, and a carbodiimide group. Effect of the Invention
[0009] The ultrafiltration membrane of the present invention has excellent biological material adhesion suppression ability, and therefore can reduce problems such as membrane permeation inhibition and sample loss. The ultrafiltration membrane of the present invention can be obtained by applying a coating membrane to a commercially available ultrafiltration membrane through a simple operation. Furthermore, the obtained ultrafiltration membrane has excellent adhesion of the coating membrane to the membrane material, so that even when used in ultrafiltration using a centrifuge, peeling of the coating membrane due to centrifugal force is not observed. Therefore, the ultrafiltration membrane of the present invention is suitable for use in ultrafiltration using a centrifuge. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0010] <Terminology explanation> The terms used in the present invention have the following definitions unless otherwise specified.
[0011] In the present invention, a "halogen atom" means a fluorine atom, a chlorine atom, a bromine atom or an iodine atom.
[0012] In the present invention, "alkyl group" refers to a monovalent group of a linear or branched saturated aliphatic hydrocarbon. Examples of "linear or branched alkyl group having 1 to 5 carbon atoms" include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 2,2-dimethylpropyl, and 1-ethylpropyl. Examples of "linear or branched alkyl group having 1 to 6 carbon atoms" include the examples of "linear or branched alkyl group having 1 to 5 carbon atoms" as well as hexyl or isomers thereof. Similarly, examples of the "linear or branched alkyl group having 1 to 18 carbon atoms" include, in addition to the examples of the "linear or branched alkyl group having 1 to 5 carbon atoms", a hexyl group, a heptyl group, an octyl group, a nonyl group, a decyl group, an undecyl group, a dodecyl group, a tridecyl group, a tetradecyl group, a pentadecyl group, a hexadecyl group, a heptadecyl group, an octadecyl group, or an isomer thereof.
[0013] In the present invention, "a linear or branched alkyl group having 1 to 5 carbon atoms which may be substituted with a halogen atom" means the linear or branched alkyl group having 1 to 5 carbon atoms as described above, or the linear or branched alkyl group having 1 to 5 carbon atoms as described above which is substituted with one or more halogen atoms as described above. Examples of the "linear or branched alkyl group having 1 to 5 carbon atoms" are as described above. On the other hand, "a linear or branched alkyl group having 1 to 5 carbon atoms which is substituted with one or more halogen atoms" means the linear or branched alkyl group having 1 to 5 carbon atoms as described above in which one or more arbitrary hydrogen atoms are replaced with a halogen atom, and examples thereof include a fluoromethyl group, a difluoromethyl group, a trifluoromethyl group, a chloromethyl group, a dichloromethyl group, a trichloromethyl group, a bromomethyl group, an iodomethyl group, a 2,2,2-trifluoroethyl group, a 2,2,2-trichloroethyl group, a perfluoroethyl group, a perfluorobutyl group, and a perfluoropentyl group.
[0014] In the present invention, an "ester bond" means -C(=O)-O- or -OC(=O)-, an "amide bond" means -NHC(=O)- or -C(=O)NH-, an ether bond means -O-, and an "acetal bond" is as shown below: [ka] means.
[0015] In the present invention, "a linear or branched alkylene group having 1 to 10 carbon atoms which may be substituted with one or more halogen atoms" means a linear or branched alkylene group having 1 to 10 carbon atoms, or a linear or branched alkylene group having 1 to 10 carbon atoms which is substituted with one or more halogen atoms. Here, the "alkylene group" means a divalent organic group corresponding to the above alkyl group. Examples of the "linear or branched alkylene group having 1 to 10 carbon atoms" include a methylene group, an ethylene group, a propylene group, a trimethylene group, a tetramethylene group, a 1-methylpropylene group, a 2-methylpropylene group, a dimethylethylene group, an ethylethylene group, a pentamethylene group, a 1-methyl-tetramethylene group, a 2-methyl-tetramethylene group, a 1,1-dimethyl-trimethylene group, a 1,2-dimethyl-trimethylene group, a 2,2-dimethyl-trimethylene group, a 1-ethyl-trimethylene group, a hexamethylene group, an octamethylene group, and a decamethylene group. Of these, an ethylene group, a propylene group, an octamethylene group, and a decamethylene group are preferred, and a linear or branched alkylene group having 1 to 5 carbon atoms, such as an ethylene group, a propylene group, a trimethylene group, or a tetramethylene group, is more preferred, and an ethylene group or a propylene group is particularly preferred. The "linear or branched alkylene group having 1 to 10 carbon atoms substituted with one or more halogen atoms" means the above-mentioned alkylene group in which any one or more hydrogen atoms are replaced with halogen atoms, and in particular, an ethylene group or a propylene group in which some or all of the hydrogen atoms are replaced with halogen atoms is preferred.
[0016] In the present invention, the term "cyclic hydrocarbon group having 3 to 10 carbon atoms" refers to a monocyclic or polycyclic, saturated or partially unsaturated, aliphatic hydrocarbon monovalent group having 3 to 10 carbon atoms. Among these, a monovalent, monocyclic or bicyclic, saturated aliphatic hydrocarbon group having 3 to 10 carbon atoms is preferred, and examples thereof include cycloalkyl groups having 3 to 10 carbon atoms, such as a cyclopropyl group, a cyclobutyl group, or a cyclohexyl group, or a bicycloalkyl group having 4 to 10 carbon atoms, such as a bicyclo[3.2.1]octyl group, a bornyl group, or an isobornyl group.
[0017] In the present invention, the term "aryl group having 6 to 10 carbon atoms" refers to a monovalent monocyclic or polycyclic aromatic hydrocarbon group having 6 to 10 carbon atoms, such as a phenyl group, a naphthyl group, an anthryl group, etc. The "aryl group having 6 to 10 carbon atoms" may be substituted with one or more of the above-mentioned "linear or branched alkyl group having 1 to 5 carbon atoms which may be substituted with a halogen atom".
[0018] In the present invention, the "aralkyl group having 7 to 14 carbon atoms" refers to a group -R-R' (wherein R represents the above-mentioned "alkylene group having 1 to 5 carbon atoms" and R' represents the above-mentioned "aryl group having 6 to 10 carbon atoms"), and examples thereof include a benzyl group, a phenethyl group, an α-methylbenzyl group, etc. The aryl portion of the "aralkyl group having 7 to 14 carbon atoms" may be substituted with one or more of the above-mentioned "linear or branched alkyl groups having 1 to 5 carbon atoms which may be substituted with a halogen atom".
[0019] In the present invention, "aryloxyalkyl group having 7 to 14 carbon atoms" means a group -RO-R' (wherein R represents the above-mentioned "alkylene group having 1 to 5 carbon atoms" and R' represents the above-mentioned "aryl group having 6 to 10 carbon atoms"), and examples thereof include a phenoxymethyl group, a phenoxyethyl group, and a phenoxypropyl group. The aryl portion of the "aryloxyalkyl group having 7 to 14 carbon atoms" may be substituted with one or more of the above-mentioned "linear or branched alkyl group having 1 to 5 carbon atoms which may be substituted with a halogen atom".
[0020] In the present invention, the term "halide ion" means a fluoride ion, a chloride ion, a bromide ion, or an iodide ion. In the present invention, the term "inorganic acid ion" means a carbonate ion, a sulfate ion, a phosphate ion, a hydrogen phosphate ion, a dihydrogen phosphate ion, a nitrate ion, a perchlorate ion, or a borate ion. The above An -Preferred as the cation are halide ions, sulfate ions, phosphate ions, hydroxide ions and isothiocyanate ions, and particularly preferred are halide ions.
[0021] In the present invention, the (meth)acrylate compound means both an acrylate compound and a methacrylate compound. For example, (meth)acrylic acid means acrylic acid and methacrylic acid.
[0022] In the present invention, the term "anionic monomer" refers to a monomer having an anionic group, including a monomer having a group that can dissociate in water to become anionic. Similarly, in the present invention, the term "cationic monomer" refers to a monomer having a cationic group, including a monomer having a group that can dissociate in water to become cationic.
[0023] Description of the invention The present invention relates to an ultrafiltration membrane comprising a coating membrane having an ability to inhibit adhesion of biological materials on at least a part of its surface. Ultrafiltration generally refers to a filtration operation carried out using a porous filtration membrane having a nominal molecular weight cutoff (NMWL) of, for example, 1 to 1000 kDa for the purpose of concentrating viruses, concentrating proteins, purifying nucleic acids, etc., and the ultrafiltration membrane refers to a membrane to be subjected to ultrafiltration.
[0024] Known forms of ultrafiltration membranes include hollow fiber membranes, spiral membranes, tubular membranes and flat membranes, and a preferred embodiment of the ultrafiltration membrane of the present invention is a flat membrane.
[0025] In addition, other forms of ultrafiltration membranes are roughly classified into a type in which the membrane is housed in a casing (container) (casing type) and a type in which the membrane is not housed in a casing (non-casing type), and a preferred embodiment of the ultrafiltration membrane of the present invention is the casing type. An example of the casing type is a centrifugal ultrafiltration filter unit having a two-layer structure of a filter unit equipped with an ultrafiltration membrane and a tube for collecting filtrate, for use in ultrafiltration using a centrifuge.
[0026] Furthermore, the use forms of ultrafiltration using ultrafiltration membranes can be broadly divided into normal flow filtration (vertical filtration), in which the sample liquid flow is sent vertically to the membrane surface, and cross-flow filtration (horizontal filtration), in which the sample liquid flow is sent horizontally along the membrane surface. A preferred use form of ultrafiltration using the ultrafiltration membrane of the present invention is normal flow filtration (vertical filtration).
[0027] The material of the ultrafiltration membrane of the present invention before application of the coating membrane (uncoated ultrafiltration membrane) is not particularly limited as long as it is a known material that can be used as an ultrafiltration membrane, and may be any of natural resins or derivatives thereof, or synthetic resins. Preferred examples of natural resins or derivatives thereof include cellulose, regenerated cellulose, cellulose acetate (CA), nitrocellulose (NC), and cellulose with immobilized dextran sulfate. Preferred examples of synthetic resins include polyamide (PA), polyacrylonitrile (PAN), polyester polymer alloy (PEPA), polystyrene (PS), polysulfone (PSF), polyethylene terephthalate (PET), polymethyl methacrylate (PMMA), polyvinyl alcohol (PVA), polyurethane (PU), ethylene vinyl alcohol (EVAL), polyethylene (PE), polyester, polypropylene (PP), polyvinylidene fluoride (PVDF), polyethersulfone (PES), polycarbonate (PC), polyvinyl chloride (PVC), polytetrafluoroethylene (PTFE), ultra-high molecular weight polyethylene (UHPE), cycloolefin polymer (COP), cycloolefin copolymer (COC), polydimethylsiloxane (PDMS), acrylonitrile-butadiene-styrene resin (ABS), Teflon (registered trademark), and hydrophilized materials thereof.
[0028] The material of the ultrafiltration membrane may be one type or a combination of two or more types. Among these materials, regenerated cellulose, cellulose acetate (CA), polyamide (PA), polyacrylonitrile (PAN), polyvinyl alcohol (PVA), polyethylene (PE), polypropylene (PP), polyvinylidene fluoride (PVDF), polyethersulfone (PES), polytetrafluoroethylene (PTFE), Teflon (registered trademark), or a hydrophilic material thereof, or a combination selected from these, is preferable, and regenerated cellulose, polyamide (PA), polypropylene (PP), polyethersulfone (PES), polytetrafluoroethylene (PTFE), or a hydrophilic material thereof is particularly preferable.
[0029] The coating membrane provided on the ultrafiltration membrane of the present invention has the ability to inhibit adhesion of biological materials.
[0030] The coating membrane may be formed on at least a portion of the surface of the ultrafiltration membrane, but it is preferable that the coating membrane is formed over the entire surface that may come into contact with a sample containing the biological material to be filtered, and it is even more preferable that the coating membrane is formed over the entire surface of the ultrafiltration membrane.
[0031] In the present invention, biological materials include proteins, sugars, lipids, viruses, nucleic acids, cells, extracellular vesicles (EVs), or combinations thereof, or biological tissues and body fluids containing them. The above proteins include fibrinogen, bovine serum albumin (BSA), human albumin, various globulins, β-lipoprotein, various antibodies (IgG, IgA, IgM), peroxidase, various complements, various lectins, fibronectin, lysozyme, von Willebrand factor (vWF), serum γ-globulin, pepsin, ovalbumin, insulin, histones, ribonuclease, collagen, cytochrome c, The sugars include glucose, galactose, mannose, fructose, heparin, hyaluronic acid, The nucleic acids include deoxyribonucleic acid (DNA), ribonucleic acid (RNA), The above cells include fibroblasts, bone marrow cells, B lymphocytes, T lymphocytes, neutrophils, red blood cells, platelets, macrophages, monocytes, bone cells, pericytes, dendritic cells, keratinocytes, adipocytes, mesenchymal cells, epithelial cells, epidermal cells, endothelial cells, vascular endothelial cells, liver parenchymal cells, chondrocytes, cumulus cells, nervous system cells, glial cells, neurons, oligodendrocytes, microglia, astrocytes, cardiac cells, esophageal cells, muscle cells (e.g., smooth muscle cells or skeletal muscle cells), pancreatic beta cells, melanocytes, hematopoietic progenitor cells, mononuclear cells, embryonic stem cells (ES cells), embryonic tumor cells, embryonic germ stem cells, artificial Examples of such cells include pluripotent stem cells (iPS cells), neural stem cells, hematopoietic stem cells, mesenchymal stem cells, hepatic stem cells, pancreatic stem cells, muscle stem cells, germline stem cells, intestinal stem cells, cancer stem cells, hair follicle stem cells, and various cell lines (e.g., HCT116, Huh7, HEK293 (human fetal kidney cells), HeLa (human cervical cancer cell line), HepG2 (human hepatic cancer cell line), UT7 / TPO (human leukemia cell line), CHO (Chinese hamster ovary cell line), MDCK, MDBK, BHK, C-33A, HT-29, AE-1, 3D9, Ns0 / 1, Jurkat, NIH3T3, PC12, S2, Sf9, Sf21, High Five, and Vero).
[0032] Lipids are broadly classified into simple lipids such as neutral fats, complex lipids such as phospholipids and lipoproteins, and derived lipids such as steroids containing fatty acids and cholesterol, but any of these may be used, and examples include cholesterol; fat-soluble vitamins such as vitamin E (tocopherols, tocotrienols), vitamin A, vitamin D, and vitamin K; fatty acids; intermediate metabolites such as acylcarnitine and acyl CoA; glycolipids; glycerides; and derivatives thereof.
[0033] Viruses are broadly classified into enveloped and non-enveloped viruses, but may be any of them. Enveloped viruses are selected from the Coronaviridae, Orthomyxoviridae, Flaviviridae, Togaviridae, Paramyxoviridae, Rhabdoviridae, Bunyaviridae, Filoviridae, Herpesviridae, Poxviridae, Hepadnaviridae, and Retroviridae families, and specific examples thereof include SARS-CoV-2, SARS-CoV, MERS coronavirus, influenza virus, hepatitis C virus, Japanese encephalitis virus, Zika virus, rubella virus, measles virus, human respiratory syncytial virus, rabies virus, Crimean-Congo hemorrhagic fever virus, varicella-zoster virus, smallpox virus, hepatitis B virus, human immunodeficiency virus, adult T-cell leukemia virus, Sendai virus, retrovirus, and lentivirus. Non-enveloped viruses are selected from the Reoviridae, Caliciviridae, Picornaviridae, Astroviridae, Hepeviridae, Parvoviridae, Polyomaviridae, Papillomaviridae, and Adenoviridae families, and specific examples include reovirus, rotavirus, Colorado tick fever virus, Norwalk virus, Sapporo virus, poliovirus, Coxsackievirus A, Coxsackievirus B, enterovirus, rhinovirus, hepatitis A virus, astrovirus, hepatitis E virus, B19 virus, JC virus, hylopaviromavirus, feline calicivirus, human adenovirus, and adeno-associated virus.
[0034] The biological material in the present invention may be a material that can be administered to a living body and act thereon. Examples of such materials include low molecular weight pharmaceuticals such as peptides (cyclic peptides) and low molecular weight compounds, and biopharmaceuticals such as enzymes, blood coagulation and fibrinolysis factors, serum proteins, hormones, vaccines, interferons, erythropoietins, cytokines, toxins, antibodies, antibody-drug conjugates, and fusion proteins.
[0035] The ability to inhibit adhesion of biological materials means, for example, When the biological material is a protein, the relative mass per unit area (%) ((mass per unit area (ng / cm) in the examples) compared to when there is no coating film is measured by QCM-D measurement performed by the method described in the examples of WO 2016 / 093293. 2 ) / (Mass per unit area of comparative example (ng / cm 2 ))) is 50% or less, preferably 30% or less, and more preferably 20% or less; When the biological material is a cell, this means that the relative absorbance (WST OD450nm) (%) ((absorbance (WST OD450nm) of the example) / (absorbance (WST OD450nm) of the comparative example)) compared to that without a coating film, as measured by a fluorescence microscope using the method described in the examples of WO 2016 / 093293, is 50% or less, preferably 30% or less, and more preferably 20% or less.
[0036] The ultrafiltration membrane of the present invention is preferably for the separation, purification and / or concentration of biological materials.
[0037] The coating film having the ability to inhibit adhesion of biological materials according to the present invention may contain an ethylenically unsaturated monomer, or a polymer obtained by polymerization of a polysaccharide or a derivative thereof, or a cured product thereof. Examples of the ethylenically unsaturated monomer include one or more ethylenically unsaturated monomers selected from the group consisting of (meth)acrylic acid esters, vinyl acetate, vinylpyrrolidone, ethylene, vinyl alcohol, and hydrophilic functional derivatives thereof. Examples of polysaccharides or derivatives thereof include cellulose-based polymers such as hydroxyalkyl cellulose (e.g., hydroxyethyl cellulose or hydroxypropyl cellulose), starch, dextran, and curdlan.
[0038] The hydrophilic functional derivative refers to an ethylenically unsaturated monomer having a hydrophilic functional group or structure. Examples of the hydrophilic functional group or structure include a hydroxyl group, a betaine structure, an amide structure, an alkylene glycol residue, an amino group, and a sulfinyl group.
[0039] The betaine structure means a monovalent or divalent group of a compound having an amphoteric center of a quaternary ammonium type cation structure and an acidic anion structure, for example, a phosphorylcholine group: [ka] An example of an ethylenically unsaturated monomer having such a structure is 2-methacryloyloxyethyl phosphorylcholine (MPC).
[0040] The amide structure has the following formula: [ka] [Where, R 16 , R 17 and R 18 are each independently a hydrogen atom or an organic group (for example, an optionally substituted linear or branched alkyl group having 1 to 5 carbon atoms, specifically, a methyl group, an isopropyl group, a hydroxymethyl group, a hydroxyethyl group, etc.). It means a group represented by the following formula: Examples of ethylenically unsaturated monomers having such a structure include (meth)acrylamide, N-isopropylacrylamide, and N-(hydroxymethyl)(meth)acrylamide. Furthermore, monomers having such a structure are disclosed, for example, in JP-A-2010-169604.
[0041] The alkylene glycol residue means an alkyleneoxy group (-Alk-O-) remaining after one or both terminal hydroxyl groups of alkylene glycol (HO-Alk-OH; where Alk is an alkylene group having 1 to 10 carbon atoms) undergoes a condensation reaction with another compound, and also includes a poly(alkyleneoxy) group in which alkyleneoxy units are repeated. Examples of ethylenically unsaturated monomers having such a structure include 2-hydroxyethyl (meth)acrylate, methoxypolyethylene glycol (meth)acrylate, etc. Furthermore, monomers having such a structure are disclosed, for example, in JP 2008-533489 A and the like.
[0042] The amino group has the formula: -NH2, -NHR 19 or -NR 20 R 21 [Where, R 19 , R 20 and R 21 are each independently an organic group (e.g., a straight-chain or branched alkyl group having 1 to 5 carbon atoms). The amino group in the present invention includes quaternized or salified amino groups. Examples of ethylenically unsaturated monomers having such a structure include dimethylaminoethyl (meth)acrylate, 2-(t-butylamino)ethyl (meth)acrylate, and methacryloylcholine chloride.
[0043] The sulfinyl group has the formula: [ka] [Where, R 22 is an organic group (e.g., an organic group having 1 to 10 carbon atoms, preferably an alkyl group having 1 to 10 carbon atoms having one or more hydroxyl groups, etc.). The sulfinyl group may be introduced by the method disclosed in JP-A-2014-48278, etc.
[0044] Furthermore, the copolymer described in International Publication No. 2014 / 196650 can be used as the polymer contained in the coating film capable of inhibiting adhesion of a biological material according to the present invention. The copolymer is a polymer of an ethylenically unsaturated monomer, and contains a repeating unit containing an organic group represented by the following formula (a) and a repeating unit containing an organic group represented by the following formula (b). [ka] [In the formula, U a11 , U a12 , U b11 , U b12 and U b13 each independently represents a hydrogen atom or a linear or branched alkyl group having 1 to 5 carbon atoms; An - represents an anion selected from the group consisting of a halide ion, an inorganic acid ion, a hydroxide ion, and an isothiocyanate ion. The entire disclosures of WO 2014 / 196650 and WO 2016 / 093293 are incorporated by reference into this application.
[0045] In addition, as the polymer containing the coating film having the ability to inhibit adhesion of biological material according to the present invention, an acetalized product of poly(vinyl alcohol / vinyl acetate) copolymer described in JP 2003-292477 A, WO 2013 / 153873 A, etc. can be used. The acetalized product of poly(vinyl alcohol / vinyl acetate) copolymer is a photosensitive resin in which a photosensitive compound having at least one azide group is pendant via an acetal bond to a copolymer having a structure in which at least two repeating units formed of vinyl alcohol are continuous. Examples of photosensitive compounds having at least one azide group that are subjected to acetalization include 2-(3-(4-azidophenyl)prop-2-enoylamino)-N-(4,4-dimethoxybutyl)-3-(3-pyridyl)prop-2-enamide], 3-[4-azidophenyl]-N-(3-formyl)propyl-2-[morpholinomethylphenylcarbonylamino]propenamide, etc. The entire disclosures of JP 2003-292477 A and WO 2013 / 153873 A are incorporated by reference into this application.
[0046] The coating film having the ability to inhibit adhesion of biological materials according to the present invention may contain a cured product of a polymer obtained by polymerization of an ethylenically unsaturated monomer, or a polysaccharide or a derivative thereof. Curing preferably proceeds via one or more crosslinking groups selected from the group consisting of an azide group, a diazo group, a diazide group, and a carbodiimide group. Such a crosslinking group may be one that has been introduced into the polymer, or one that a crosslinking component that has been blended into the polymer possesses. Furthermore, depending on the type of crosslinking group, curing proceeds by irradiation with light or heating to form a cured product.
[0047] The method for producing an ultrafiltration membrane having the ability to inhibit the adhesion of biological material of the present invention includes a step of applying a coating film-forming composition having the ability to inhibit the adhesion of biological material to at least a portion of the surface of an (uncoated) ultrafiltration membrane, and a step of drying the applied composition.
[0048] Hereinafter, one embodiment of the coating film-forming composition according to the present invention and the method for producing an ultrafiltration membrane having the ability to inhibit adhesion of biological material according to the present invention using the same will be described using as an example a coating film-forming composition containing (1) a monomer mixture containing an anionic monomer represented by formula (A), a cationic monomer represented by formula (B), a hydrophobic monomer represented by formula (C), and a bifunctional monomer represented by formula (D), wherein the total ratio of the anionic monomer represented by formula (A) and the cationic monomer represented by formula (B) to the total monomers contained in the monomer mixture is 40 mol % or more, and (2) a polycarbodiimide having a structure represented by formula (E).
[0049] The monomer mixture has formula (A): [ka] (In the formula, T a , Ua1 and U a2 each independently represents a hydrogen atom or a linear or branched alkyl group having 1 to 5 carbon atoms; Q a represents a single bond, an ester bond or an amide bond; R a represents a linear or branched alkylene group having 1 to 10 carbon atoms which may be substituted with a halogen atom; m represents an integer from 1 to 10. The anionic monomer may contain two or more kinds of anionic monomers represented by formula (A).
[0050] In one embodiment of the anionic monomer of formula (A), T a is preferably a hydrogen atom, a methyl group, or an ethyl group, and more preferably a hydrogen atom or a methyl group. a1 and U a2 is preferably a hydrogen atom, a methyl group or an ethyl group, and more preferably a hydrogen atom. a R is preferably a single bond or an ester bond, and more preferably an ester bond. a is preferably a methylene group, an ethylene group or a propylene group which may be substituted with a chlorine atom, and more preferably an ethylene group or a propylene group. m is preferably an integer of 2 to 8, and more preferably an integer of 3 to 6.
[0051] Specific examples of the monomer of the above formula (A) include acid phosphooxyethyl (meth)acrylate, 3-chloro-2-acid phosphooxypropyl (meth)acrylate, acid phosphooxypropyl (meth)acrylate, acid phosphooxymethyl (meth)acrylate, acid phosphooxypolyoxyethylene glycol mono(meth)acrylate, and acid phosphooxypolyoxypropylene glycol mono(meth)acrylate, and among these, acid phosphooxyethyl methacrylate (=2-(methacryloyloxy)ethyl phosphate), acid phosphooxypolyoxyethylene glycol monomethacrylate, and acid phosphooxypolyoxypropylene glycol monomethacrylate are preferably used.
[0052] The structural formulas of acid phosphooxyethyl methacrylate (=2-(methacryloyloxy)ethyl phosphate), acid phosphooxy polyoxyethylene glycol monomethacrylate, and acid phosphooxy polyoxypropylene glycol monomethacrylate are represented by the following formulas (A-1) to (A-3), respectively.
[0053] [ka]
[0054] The monomer mixture may be a monomer mixture of formula (B): [ka] (In the formula, T b , U b1 , U b2 and U b3 each independently represents a hydrogen atom or a linear or branched alkyl group having 1 to 5 carbon atoms; Q b represents a single bond, an ester bond or an amide bond; R b represents a linear or branched alkylene group having 1 to 10 carbon atoms which may be substituted with a halogen atom; An - represents an anion selected from the group consisting of a halide ion, an inorganic acid ion, a hydroxide ion, and an isothiocyanate ion. The cationic monomer represented by the formula (B) may contain two or more cationic monomers represented by the formula (B).
[0055] In one embodiment of the cationic monomer represented by formula (B), T b is preferably a hydrogen atom, a methyl group, or an ethyl group, and more preferably a hydrogen atom or a methyl group. b1 , U b2 and U b3 are each independently preferably a hydrogen atom, a methyl group, an ethyl group, or a t-butyl group, and more preferably a methyl group or an ethyl group. b R is preferably a single bond or an ester bond, and more preferably an ester bond. b As the alkyl group, a methylene group, an ethylene group or a propylene group which may be substituted with a chlorine atom is preferable, and an ethylene group or a propylene group is more preferable. - As the cation, a halide ion is preferred, and a chloride ion is more preferred.
[0056] Specific examples of the monomer of the above formula (B) include dimethylaminoethyl (meth)acrylate, diethylaminoethyl (meth)acrylate, dimethylaminopropyl (meth)acrylate, 2-(t-butylamino)ethyl (meth)acrylate, methacryloylcholine chloride, and the like. Among these, dimethylaminoethyl (meth)acrylate, methacryloylcholine chloride, and 2-(t-butylamino)ethyl (meth)acrylate are preferably used.
[0057] The structural formulas of dimethylaminoethyl acrylate (= 2-(dimethylamino)ethyl acrylate), diethylaminoethyl methacrylate (= 2-(diethylamino)ethyl methacrylate), dimethylaminoethyl methacrylate (= 2-(dimethylamino)ethyl methacrylate), methacryloylcholine chloride and 2-(t-butylamino)ethyl methacrylate (= 2-(t-butylamino)ethyl methacrylate) are represented by the following formulas (B-1) to (B-5), respectively.
[0058] [ka]
[0059] The monomer mixture may be a monomer mixture of formula (C): [ka] [In the formula, T c represents a hydrogen atom or a linear or branched alkyl group having 1 to 5 carbon atoms; Q c represents a single bond, an ether bond or an ester bond; R c represents a linear or branched alkyl group having 1 to 18 carbon atoms, a cyclic hydrocarbon group having 3 to 10 carbon atoms, an aryl group having 6 to 10 carbon atoms, an aralkyl group having 7 to 14 carbon atoms, or an aryloxyalkyl group having 7 to 14 carbon atoms (wherein the aryl moiety may be substituted with a linear or branched alkyl group having 1 to 5 carbon atoms which may be substituted with a halogen atom) The hydrophobic monomer may contain two or more hydrophobic monomers represented by formula (C).
[0060] In one embodiment of the hydrophobic monomer of formula (C), T c is preferably a hydrogen atom, a methyl group, or an ethyl group, and more preferably a hydrogen atom or a methyl group. c R is preferably a single bond or an ester bond, and more preferably an ester bond.c As the alkyl group, a linear or branched alkyl group having 1 to 18 carbon atoms or a cyclic hydrocarbon group having 3 to 10 carbon atoms is preferable, and a linear or branched alkyl group having 1 to 6 carbon atoms or a cycloalkyl group having 3 to 10 carbon atoms is more preferable.
[0061] Specific examples of the monomer of the formula (C) include linear or branched alkyl esters of (meth)acrylic acid such as butyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, lauryl (meth)acrylate, and stearyl (meth)acrylate; cyclic alkyl esters of (meth)acrylic acid such as cyclohexyl (meth)acrylate and isobornyl (meth)acrylate; aralkyl esters of (meth)acrylic acid such as benzyl (meth)acrylate and phenethyl (meth)acrylate; styrene-based monomers such as styrene, methylstyrene, and chloromethylstyrene; vinyl ether-based monomers such as methyl vinyl ether and butyl vinyl ether; and vinyl ester-based monomers such as vinyl acetate and vinyl propionate. Among these, butyl (meth)acrylate or cyclohexyl (meth)acrylate is preferably used.
[0062] The structural formulas of butyl methacrylate (=butyl methacrylate) and cyclohexyl methacrylate (=cyclohexyl methacrylate) are represented by the following formulas (C-1) and (C-2), respectively.
[0063] [ka]
[0064] The monomer mixture may be a monomer mixture of formula (D): [ka] (In the formula, T d represents a hydrogen atom or a linear or branched alkyl group having 1 to 6 carbon atoms; R drepresents a linear or branched alkylene group having 1 to 10 carbon atoms which may be substituted with a halogen atom; n represents an integer from 1 to 10. The difunctional monomer may contain two or more difunctional monomers represented by formula (D).
[0065] In one embodiment of the bifunctional monomer of formula (D), T d R is preferably a hydrogen atom, a methyl group, or an ethyl group, and more preferably a hydrogen atom or a methyl group. d is preferably a methylene group, an ethylene group or a propylene group which may be substituted with a chlorine atom, and more preferably an ethylene group or a propylene group.
[0066] Specific examples of the bifunctional monomer of the above formula (D) include poly(ethylene glycol) di(meth)acrylate, poly(trimethylene glycol) di(meth)acrylate, poly(propylene glycol) di(meth)acrylate, and the like.
[0067] For example, the structural formulas of ethylene glycol dimethacrylate, poly(ethylene glycol) dimethacrylate, and poly(propylene glycol) dimethacrylate are represented by the following formulas (D-1) to (D-3), respectively.
[0068] [ka]
[0069] In the monomer mixture, the total ratio of the anionic monomer represented by formula (A) and the cationic monomer represented by formula (B) to the total monomers is 40 mol% or more, preferably 40 mol% to 70 mol%, more preferably 40 mol% to 60 mol%, and particularly preferably 40 mol% to 55 mol%. The ratio (molar ratio) of the anionic monomer represented by formula (A) to the cationic monomer represented by formula (B) is not particularly limited, but is preferably in the range of 1:2 to 2:1, more preferably 1:1.5 to 1.5:1, and particularly preferably 1:1.2 to 1.2:1.
[0070] In the monomer mixture, the ratio of the bifunctional monomer represented by the formula (D) to the total monomer is preferably less than 30 mol%, preferably 5 mol% or more and less than 30 mol%, more preferably 10 mol% or more and less than 30 mol%, particularly preferably 15 mol% or more and less than 30 mol%. In particular, in the case where post-crosslinking by a crosslinking agent can be expected in the coating membrane applied to the ultrafiltration membrane of the present invention, the ratio of the bifunctional monomer in the monomer mixture can also be reduced.
[0071] In the monomer mixture, the ratio of the hydrophobic monomer represented by the formula (C) to the total monomers may be the entire remainder after subtracting the ratios of the monomers of the formulae (A), (B), and (D) to the total monomers, or may be the remainder after subtracting the total ratio of the monomers of the formulae (A), (B), and (D) and any monomer component described below. For example, the ratio is from 1 mol% to 55 mol%, preferably from 3 mol% to 50 mol%, and more preferably from 5 mol% to 50 mol%.
[0072] The weight molecular weight of the polymer contained in the composition for forming a coating film may be several thousand to several million, preferably 5,000 to 5,000,000, and more preferably 10,000 to 2,000,000. The polymer may be any of a random copolymer, a block copolymer, and a graft copolymer, but a random copolymer is preferred.
[0073] The polymer contained in the coating film-forming composition is obtained by polymerizing a monomer mixture containing the monomers represented by the above formulas (A) to (D) (and optionally any monomer components). The polymerization can be carried out by a method known per se (for example, the method described in JP 2014-162865 A and WO 2020 / 040247 A). For example, it can be synthesized by a method such as radical polymerization, anionic polymerization, or cationic polymerization, which is a method for synthesizing a general acrylic polymer or methacrylic polymer. The form can be various methods such as solution polymerization, suspension polymerization, emulsion polymerization, and bulk polymerization.
[0074] The polymer can be prepared, for example, by a production method including a step of reacting (polymerizing) the monomers represented by the above formulas (A) to (D) in a solvent.
[0075] The reaction conditions are as follows: a reaction vessel containing various raw materials (monomers, solvent, initiator, etc.) is heated to 50°C to 200°C in an oil bath or the like, and the mixture is stirred for 1 to 48 hours, more preferably at 80°C to 150°C, for 5 to 30 hours, to progress the polymerization reaction and obtain the copolymer according to the present invention. The reaction atmosphere is preferably a nitrogen atmosphere.
[0076] The solvent in the polymerization reaction may be water, a phosphate buffer solution, an alcohol such as ethanol, or a mixed solvent of these, but preferably contains water or ethanol. It is more preferable that the solvent contains 10% by mass or more and 100% by mass or less of water or ethanol. It is more preferable that the solvent contains 50% by mass or more and 100% by mass or less of water or ethanol. It is more preferable that the solvent contains 80% by mass or more and 100% by mass or less of water or ethanol. It is more preferable that the solvent contains 90% by mass or more and 100% by mass or less of water or ethanol. Preferably, the total of water and ethanol is 100% by mass.
[0077] As a reaction procedure, all the raw materials may be put into a reaction solvent at room temperature and then heated to the above temperature to polymerize, or the mixture of the raw materials may be added dropwise in small portions to a pre-heated solvent. For example, the anionic monomer represented by formula (A) is a monomer that easily associates, so it may be added dropwise in small portions to the reaction solvent so that it can be dispersed quickly when added dropwise to the reaction system. In this case, the reaction solvent may be heated (for example, 40°C to 100°C) to increase the solubility of the monomer and polymer.
[0078] In order to efficiently proceed with the polymerization reaction, it is desirable to use a polymerization initiator, particularly a radical polymerization initiator. Examples of radical polymerization initiators include azo polymerization initiators such as dimethyl 1,1'-azobis(1-cyclohexanecarboxylate) (VE-073, Fujifilm Wako Pure Chemical Industries, Ltd.), 2,2'-azobis(2,4-dimethylvaleronitrile) (V-65, Fujifilm Wako Pure Chemical Industries, Ltd.), 2,2'-azobis(isobutyronitrile) (AIBN, Fujifilm Wako Pure Chemical Industries, Ltd.), 2,2'-azobis[N-(2-carboxyethyl)-2-methylpropionamidine]n hydrate (VA-057, Fujifilm Wako Pure Chemical Industries, Ltd.), and 2,2'-(N-butyl-2-methylpropionamide) (VAm-110, Fujifilm Wako Pure Chemical Industries, Ltd.).
[0079] The amount of the polymerization initiator added is 0.05% by mass to 10% by mass based on the total weight of the monomers used in the polymerization.
[0080] After completion of the reaction, the obtained polymer may be isolated and purified by a known method, for example, by adding a poor solvent to the reaction solution, but the reaction solution may be used as it is as a copolymer-containing solution for preparing the coating film-forming composition of the present invention.
[0081] The polycarbodiimide has the following formula (E): [ka] The structure includes:
[0082] In one embodiment of the present invention, the reaction between the polymer and the polycarbodiimide is considered to proceed according to the following reaction formula: As shown in this reaction formula, the carbodiimide promotes dehydration condensation between phosphate groups, forming a pyrophosphate structure between the polymers, which is considered to promote the crosslinking reaction (hardening) of the polymer.
[0083] [ka]
[0084] The polycarbodiimide may be a polycarbodiimide compound derived from an aliphatic diisocyanate compound having at least one primary isocyanate group, The polycarbodiimide compound may have a structure in which all ends are blocked with an organic compound having a functional group reactive with an isocyanate group.
[0085] For example, the aliphatic diisocyanate compound having at least one primary isocyanate group may be at least one selected from the group consisting of chain aliphatic isocyanate compounds such as ethylene diisocyanate, tetramethylene diisocyanate, hexamethylene diisocyanate, and 2,2,4-trimethylhexamethylene diisocyanate, cyclic aliphatic diisocyanate compounds such as isophorone diisocyanate, 1,3-bis(isocyanatomethyl)cyclohexane, and norbornane diisocyanate, and aliphatic diisocyanate compounds having an aromatic ring such as xylylene diisocyanate.
[0086] The polycarbodiimide may be, for example, an isocyanate-terminated polycarbodiimide having at least two carbodiimide groups represented by the formula (E) in the molecule, which is obtained by a condensation reaction accompanied by decarbonation of an aliphatic diisocyanate compound having at least one primary isocyanate group, or may be a polycarbodiimide having a structure in which the terminals are blocked with an organic compound having a functional group that reacts with an isocyanate group.
[0087] The functional group of the organic compound may be at least one selected from a hydroxy group, an amino group, an isocyanate group, an epoxy group, and a carboxy group.
[0088] Examples of the organic compound include organic compounds having a hydroxy group, such as polyethylene glycol monomethyl ether, polyethylene glycol monoethyl ether, polypropylene glycol monomethyl ether, polypropylene glycol monoethyl ether, triethylene glycol monomethyl ether, triethylene glycol monoethyl ether, tetraethylene glycol monomethyl ether, tetraethylene glycol monoethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, ethyl alcohol, propyl alcohol, butyl alcohol, pentyl alcohol, hexyl alcohol, octyl alcohol, and dodecyl alcohol; methylamine, ethylamine, propylamine, butylamine, pentylamine, hexylamine, octylamine, dodecylamine, diethylamine, dipropylamine, dibutylamine, and cyclohexylamine. , organic compounds having an amino group such as adamantaneamine, allylamine, polyoxyethylene laurylamine, polyoxymethylene stearylamine, aniline, diphenylamine, 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, N-phenyl-3-aminopropyltrimethoxysilane, 2,2-difluoroamine, fluorobenzylamine, trifluoroethylamine, [[4-(trifluoromethyl)cyclohexyl]methyl]amine, and derivatives thereof; organic compounds having an isocyanate group such as butyl isocyanate, pentyl isocyanate, hexyl isocyanate, octyl isocyanate, dodecyl isocyanate, cyclohexyl isocyanate, 1-adamantyl isocyanate, 3-isocyanatopropyltriethoxysilane, 2-isocyanatoethyl acrylate, benzyl isocyanate, 2-phenylethyl isocyanate, and derivatives thereof;Organic compounds having an epoxy group, such as 1,2-epoxyheptane, 1,2-epoxyhexane, 1,2-epoxydecane, 1,2-epoxy-5-hexene, ethyl glycidyl ether, 2-ethylhexyl glycidyl ether, glycidyl lauryl ether, allyl glycidyl ether, diethoxy(3-glycidyloxypropyl)methylsilane, 3-[2-(perfluorohexyl)ethoxy]-1,2-epoxypropane, and derivatives thereof; organic compounds having a carboxy group, such as acetic acid, ethanoic acid, propionic acid, butanoic acid, pentanoic acid, hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, decanoic acid, cyclohexanecarboxylic acid, adamantaneacetic acid, phenylacetic acid, benzoic acid, undecenoic acid, and derivatives thereof;
[0089] The organic compound may further have a hydrophilic group in addition to the functional group.
[0090] The polycarbodiimide preferably contains a hydrophilic group.
[0091] The hydrophilic group is represented by the following formula (F): [ka] (In the formula, R 1 represents a linear or branched alkyl group having 1 to 5 carbon atoms; R 2 represents a hydrogen atom or a methyl group, while R 2 If there are multiple R 2 may be the same or different, and o represents an integer of 1 to 30. It is preferable that the formula is represented by the formula:
[0092] Examples of organic compounds having a hydrophilic group, particularly a hydrophilic group represented by the above formula (F), together with a functional group that reacts with an isocyanate group include polyethylene glycol monomethyl ether (MPEG), tetraethylene glycol monomethyl ether (MTEG), etc., which may be used alone or in combination of two or more. By blocking the ends of an isocyanate-terminated polycarbodiimide with such an organic compound, a polycarbodiimide having a hydrophilic group represented by the above formula (F) introduced therein can be obtained.
[0093] As the polycarbodiimide, the polycarbodiimide compound described in WO 2018 / 194102 can be used. Other details of the polycarbodiimide compound of the present invention are in accordance with the contents described in WO 2018 / 194102.
[0094] The polycarbodiimide may be a commercially available product. Examples of the commercially available product names include "Carbodilite V-02", "Carbodilite V-02-L2", "Carbodilite SV-02", "Carbodilite V-04", "Carbodilite V-10", "Carbodilite E-02", and "Carbodilite E-05" (all of which are product names manufactured by Nisshinbo Chemical Co., Ltd.).
[0095] In one embodiment of the present invention, the coating film forming composition is obtained by mixing the above-mentioned polymer and polycarbodiimide. The ratio of polycarbodiimide to polymer is, for example, in the range of 1 to 30 parts by weight, preferably in the range of 1 to 20 parts by weight, more preferably in the range of 3 to 20 parts by weight, and particularly preferably in the range of 5 to 20 parts by weight, relative to 100 parts by weight of the polymer. In addition, when the polymer according to the present invention contains a bifunctional monomer, the ratio of polycarbodiimide to polymer in the coating film forming composition can also be reduced.
[0096] The composition for forming a coating film contains a solvent in addition to the above-mentioned polymer and polycarbodiimide. The solvent may be derived from the reaction solution of the copolymer, or may be added separately.
[0097] Examples of the solvent contained in the coating film forming composition include water, phosphate buffered saline (PBS), and alcohol. Examples of the alcohol include alcohols having 2 to 6 carbon atoms, such as ethanol, propanol, isopropanol, 1-butanol, 2-butanol, isobutanol, t-butanol, 1-pentanol, 2-pentanol, 3-pentanol, 1-heptanol, 2-heptanol, 2,2-dimethyl-1-propanol (=neopentyl alcohol), 2-methyl-1-propanol, 2-methyl-1-butanol, 2-methyl-2-butanol (=t-amyl alcohol), 3-methyl-1-butanol, 3-methyl-3-pentanol, cyclopentanol, 1-hexanol, 2-hexanol, 3-hexanol, 2,3- Examples of the solvent include dimethyl-2-butanol, 3,3-dimethyl-1-butanol, 3,3-dimethyl-2-butanol, 2-ethyl-1-butanol, 2-methyl-1-pentanol, 2-methyl-2-pentanol, 2-methyl-3-pentanol, 3-methyl-1-pentanol, 3-methyl-2-pentanol, 3-methyl-3-pentanol, 4-methyl-1-pentanol, 4-methyl-2-pentanol, 4-methyl-3-pentanol and cyclohexanol. Although a single solvent or a mixed solvent of a combination of these may be used, from the viewpoint of dissolving the copolymer, it is preferable to select from water, PBS, ethanol and propanol.
[0098] The concentration of solids in the composition for forming a coating film is preferably 0.01 to 50% by mass in order to form a uniform coating film.
[0099] Furthermore, in addition to the above-mentioned polymer, polycarbodiimide, and solvent, the composition for forming a coating film may contain other substances as required within the range that does not impair the performance of the resulting coating film. Examples of other substances include preservatives, surfactants, primers that improve adhesion to the substrate, antifungal agents, and sugars.
[0100] In order to adjust the ion balance of the copolymer in the composition for forming a coating film according to the present invention, the method for obtaining the coating film of the present invention may further include a step of adjusting the pH of the composition for forming a coating film in advance. The pH adjustment may be performed, for example, by adding a pH adjuster to a composition containing the copolymer and a solvent, and adjusting the pH of the composition to 3.0 to 13.5, preferably 3.5 to 8.5, more preferably 3.5 to 5.5, or preferably 8.5 to 13.5, more preferably 10.0 to 13.5. The type and amount of the pH adjuster that can be used are appropriately selected depending on the concentration of the copolymer, the ratio of anion to cation, and the like.
[0101] Examples of pH adjusters include organic amines such as ammonia, triethylamine, diethanolamine, pyridine, N-methyl-D-glucamine, and tris(hydroxymethyl)aminomethane; alkali metal hydroxides such as potassium hydroxide and sodium hydroxide; alkali metal halides such as potassium chloride and sodium chloride; inorganic acids or alkali metal salts thereof such as sulfuric acid, phosphoric acid, hydrochloric acid, and carbonic acid; quaternary ammonium cations such as choline, or mixtures thereof (e.g., buffer solutions such as phosphate buffered saline). Among these, ammonia, triethylamine, diethanolamine, sodium hydroxide, choline, N-methyl-D-glucamine, and tris(hydroxymethyl)aminomethane are preferred, and ammonia, triethylamine, diethanolamine, sodium hydroxide, and choline are particularly preferred.
[0102] Another embodiment of the coating film-forming composition of the present invention is a monomer mixture containing an anionic monomer represented by formula (A), a cationic monomer represented by formula (B), and a hydrophobic monomer represented by formula (C), wherein the total ratio of the anionic monomer represented by formula (A) and the cationic monomer represented by formula (B) to the total monomers contained in the monomer mixture is 40 mol % or more, and a polycarbodiimide having a structure represented by formula (E). The explanations and preferred embodiments of the monomers and polymers thereof represented by formulae (A) to (C), the polycarbodiimide having a structure represented by formula (E), and the composition for forming a coating film in the above-mentioned embodiments are applicable to other embodiments, except for those related to the bifunctional monomer represented by formula (D).
[0103] Yet another embodiment of the coating film-forming composition of the present invention is a monomer mixture containing the anionic monomer represented by formula (A), the cationic monomer represented by formula (B), the hydrophobic monomer represented by formula (C), and the bifunctional monomer represented by formula (D) among the above-mentioned polymers, in which the total ratio of the anionic monomer represented by formula (A) and the cationic monomer represented by formula (B) to the total monomers contained in the monomer mixture is 40 mol % or more, and the composition does not contain polycarbodiimide. The explanations and preferred embodiments of the monomers and polymers thereof represented by formulas (A) to (D) and the composition for forming a coating film in the above-mentioned embodiment are applicable to other embodiments, except for those related to polycarbodiimide.
[0104] One embodiment of the coating film applied to the ultrafiltration membrane of the present invention is a cured product of the coating film of the above-mentioned coating film forming composition. The cured product can be formed by applying the coating film forming composition of the present invention to at least a part of the surface of the ultrafiltration membrane and drying it. There is no particular limitation on the coating method, and a coating method such as a normal spin coating, dip coating, spray coating, or solvent casting method can be used.
[0105] Specific examples of the coating method include immersing an (uncoated) ultrafiltration membrane in the coating film forming composition, adding the coating film forming composition to a container equipped with an ultrafiltration membrane and leaving it to stand for a predetermined time, or applying the coating film forming composition to the surface of the ultrafiltration membrane. In one embodiment, in the case of a centrifugal ultrafiltration filter unit having a two-layer structure of a filter unit equipped with an ultrafiltration membrane and a tube for collecting filtrate, the coating film forming composition is added to the filter unit and left to stand for a predetermined time. The addition can be performed, for example, by adding the coating film forming composition in an amount of 0.5 to 1 times the total volume of the filter unit using a syringe or the like. The time and temperature are appropriately selected depending on the material of the ultrafiltration membrane and the components of the coating film forming composition, and the standing is performed, for example, at 10 to 80°C for 1 minute to 24 hours, preferably 5 minutes to 3 hours. This allows a coating film to be formed on at least a part of the surface of the ultrafiltration membrane, preferably over the entire surface.
[0106] The coating film is then subjected to a drying process to form a cured product. The drying process is carried out in air or vacuum at a temperature range of -200°C or higher and lower than 200°C. The cured product can be formed by drying at room temperature (10°C to 35°C, for example, 25°C), but in order to form a cured coating film more quickly, it may be dried at, for example, 40°C to 100°C. A drying process at extremely low to low temperatures (around -200°C to -30°C) by the freeze-drying method may also be used. Freeze-drying is called vacuum freeze-drying, and is a method in which the material to be dried is usually cooled with a refrigerant and the solvent is removed by sublimation in a vacuum state. Examples of common refrigerants used in freeze-drying include a mixed medium of dry ice and methanol (-78°C) and liquid nitrogen (-196°C). This drying process causes the anionic groups of the polymer to undergo a crosslinking reaction via the polycarbodiimide compound, for example, as shown in the above reaction formula, to become a cured product, thereby forming a coating film.
[0107] The coating film according to the present invention may be obtained by forming a cured product through the above steps and then washing the product. The above-mentioned washing may be performed by a known method, but washing with running water or ultrasonic washing is preferable. Examples of the washing solvent include water, an aqueous solution containing an electrolyte, and alcohol. Here, the aqueous solution containing an electrolyte is preferably PBS, physiological saline (containing only sodium chloride), Dulbecco's phosphate buffered saline, Tris buffered saline, HEPES buffered saline, and Veronal buffered saline, and PBS is particularly preferable. The alcohol is preferably an alcohol having 2 to 6 carbon atoms, and ethanol is particularly preferable. The washing solvent is preferably a water-containing alcohol solvent, which is a mixture of water or an aqueous solution containing an electrolyte and an alcohol, and more preferably a water-containing ethanol solvent, which is a mixture of water and ethanol. The washing solvent is usually used at room temperature (for example, 10 to 35°C), but may be heated to, for example, a range of 40°C to 95°C. After the adhesion, even if it is washed with water, PBS, alcohol, etc., the coating film does not dissolve and remains firmly adhered to the surface of the ultrafiltration membrane, and there is an effect that there is little change in the film thickness before and after washing, that is, there is little dissolution of the coating film into the solvent.
[0108] The coating film of the present invention has a thickness in the range of 1 to 1000 nm, and preferably in the range of 5 to 500 nm, 10 to 300 nm, 10 to 200 nm, 10 to 100 nm, or 10 to 50 nm.
[0109] Another embodiment of the coating film of the present invention is a coating film of the coating film-forming composition not containing polycarbodiimide described in the above embodiment. The coating film can be formed by applying the coating film-forming composition of the present invention to at least a part of the surface of an (uncoated) ultrafiltration membrane and drying it. The description of the method for producing the coating film in the above embodiment, particularly the method for applying the composition for forming a coating film and the drying and washing steps, and the description of preferred embodiments, etc., apply to other embodiments, except for those related to curing. EXAMPLES
[0110] The present invention will be described in more detail below with reference to Synthesis Examples, Preparation Examples, Examples, Test Examples, etc., but the present invention is not limited thereto.
[0111] <Synthesis Example 1> Acid phosphooxy polypropylene glycol monomethacrylate (average number of moles of propylene oxide added: 5; molecular weight per phosphoric acid group calculated by titration: 618) (product name: PPM-5P, manufactured by Toho Chemical Industry Co., Ltd.) 5.34 g, methacryloylcholine chloride about 80% aqueous solution (manufactured by Tokyo Chemical Industry Co., Ltd.) 2.24 g, butyl methacrylate (manufactured by Tokyo Chemical Industry Co., Ltd.) 1.90 g, ethylene glycol dimethacrylate (manufactured by Tokyo Chemical Industry Co., Ltd.) 1.51 g, ethanol (manufactured by Kanto Chemical Co., Ltd.) 47.7 g, dimethyl-1,1′-azobis(1-cyclohexanecarboxylate) (product name: VE-073, manufactured by Fujifilm Wako Pure Chemical Industries Co., Ltd.) 0.106 g were added and stirred uniformly to prepare a mixed solution. Meanwhile, 47.7 g of ethanol (Kanto Chemical Co., Ltd.) was added to a four-neck flask equipped with a cooling tube, the inside of the flask was replaced with nitrogen, and the temperature was raised to the reflux temperature while stirring. While maintaining this state, the above mixture was added dropwise over 1.5 hours, and after the addition, the mixture was heated and stirred while maintaining the above environment for 24 hours. After the reaction was completed, the mixture was cooled to obtain a copolymer-containing solution with a solid content of about 10.3 mass%.
[0112] <Preparation Example 1> 2.93 g of ethanol, 11.76 g of pure water, and 5.08 g of 1N aqueous ammonia were added to 5.00 g of the copolymer-containing solution obtained in Synthesis Example 1 above, and the mixture was thoroughly stirred. 0.62 g of a solution obtained by diluting Carbodilite V-02 (manufactured by Nisshinbo Chemical Inc., solid content approximately 40% by mass) 10 times with pure water was added thereto, and the mixture was thoroughly stirred to prepare a composition for forming a coating film. The pH was 10.0.
[0113] <Example 1> The composition for forming a coating film obtained in Preparation Example 1 was added in an amount of 500 μL to a centrifugal filter unit equipped with an ultrafiltration membrane (Amicon Ultra-0.5, Ultracel-30 membrane, 30 kDa, Merck). After standing at room temperature for 5 minutes, the composition for forming a coating film was drained, and the filter unit was then set in a 2.0 mL tube in an inverted position and centrifuged at 22°C, 1000G, and 2 minutes to completely drain the composition for forming a coating film and dry overnight at room temperature. Thereafter, the filter unit was thoroughly washed with a 70% aqueous ethanol solution and dried again at room temperature overnight to obtain a centrifugal filter unit equipped with an ultrafiltration membrane that suppresses adsorption of biological materials.
[0114] <Example 2> The composition for forming a coating film obtained in Preparation Example 1 was added in an amount of 500 μL to a centrifugal filter unit equipped with an ultrafiltration membrane (Amicon Ultra-0.5, Ultracel-100 membrane, 100 kDa, Merck). After standing at room temperature for 5 minutes, the composition for forming a coating film was drained, and the filter unit was then set in a 2.0 mL tube in an inverted position and centrifuged at 22°C, 1000G, and 2 minutes to completely drain the composition for forming a coating film and dry overnight at room temperature. Thereafter, the filter unit was thoroughly washed with a 70% aqueous ethanol solution and dried again at room temperature overnight to obtain a centrifugal filter unit equipped with an ultrafiltration membrane that suppresses adsorption of biological materials.
[0115] <Test Example 1> Albumin from bovine serum (BSA), FITC conjugate (BSA-FITC, Thermo Fisher Scientific) was adjusted to 1 μg / mL with D-PBS(-). 500 μL of the BSA-FITC solution prepared in Example 1 was added to the centrifugal filter unit obtained in Example 1. The BSA-FITC solution was filtered and concentrated by centrifugation at 22°C, 14000G, and 10 minutes, and D-PBS(-) was added to return the liquid volume to 500 μL. In addition, a similar test was also performed on a centrifugal filter unit equipped with an ultrafiltration membrane that had not been coated as a control. The fluorescence intensity (Ex. 494 nm, Em. 521 nm) of the BSA-FITC solution before centrifugation was set to 100%, and the fluorescence intensity of the BSA-FITC solution after centrifugation was measured to calculate the recovery rate of BSA-FITC. Table 1 shows the recovery rate of BSA-FITC in centrifugal filter units with and without coating, and it was confirmed that the recovery rate of BSA-FITC was improved by coating.
[0116] [Table 1]
[0117] <Test Example 2> Lyophilized exosomes from HEK293 cell line, Human (sEV, Cosmo Bio Co., Ltd.) (30 μg) were dissolved in 1 mL of D-PBS(-) and further diluted 10-fold with D-PBS(-). 500 μL of the diluted sEV solution obtained in Example 2 was added to the centrifugal filter unit obtained in Example 2. The sEV solution was filtered and concentrated by centrifugation at 8°C, 12000 rpm, and 10 minutes, and then D-PBS(-) was added to return the liquid volume to 500 μL, and the centrifugation was repeated three times at 8°C, 12000 rpm, and 10 minutes, after which D-PBS(-) was added to return the liquid volume to 500 μL. The number of particles in the sEV solution was measured after diluting 10-fold with D-PBS(-) using a nanoparticle tracking analyzer Zetaview (DKSH) under the conditions of PS100nm_488C (Sensitivity 80.0, Frame Rate 30.00, Shutter 150). As a control, a similar test was also performed on a centrifugal filter unit equipped with an uncoated ultrafiltration membrane. Table 2 shows the number of sEV particles in centrifugal filter units with and without coating, and it was confirmed that coating improves the yield of sEVs.
[0118] [Table 2] [Industrial Applicability]
[0119] The ultrafiltration membrane of the present invention has excellent biological material adhesion suppression ability, and therefore can reduce problems such as membrane permeation inhibition and sample loss. Furthermore, the ultrafiltration membrane of the present invention has excellent adhesion of the coating to the membrane material, and therefore, even when used in ultrafiltration using a centrifuge, no peeling of the coating due to centrifugal force is observed, making it suitable for use in ultrafiltration using a centrifuge.
Claims
1. An ultrafiltration membrane comprising a coating membrane having an ability to inhibit adhesion of biological material on at least a portion of its surface.
2. The ultrafiltration membrane of claim 1 , wherein the ultrafiltration membrane is a flat membrane.
3. The ultrafiltration membrane according to claim 1 , wherein the ultrafiltration is normal flow filtration.
4. The ultrafiltration membrane of claim 1 , wherein the biological material is a protein, a sugar, a lipid, a virus, a nucleic acid, a cell, an extracellular vesicle (EV), or a combination thereof.
5. 2. The ultrafiltration membrane of claim 1, which is for separating, purifying and / or concentrating biological materials.
6. The ultrafiltration membrane according to claim 1, wherein the coating membrane comprises a polymer or a cured product thereof comprising a repeating unit derived from one or more ethylenically unsaturated monomers selected from the group consisting of (meth)acrylic acid and its esters, vinyl acetate, vinylpyrrolidone, ethylene, vinyl alcohol, and hydrophilic functional derivatives thereof.
7. 7. The ultrafiltration membrane according to claim 6, wherein the coating membrane comprises a cured product of a polymer containing a repeating unit derived from one or more ethylenically unsaturated monomers selected from the group consisting of (meth)acrylic acid and esters thereof, vinyl acetate, vinylpyrrolidone, ethylene, vinyl alcohol, and hydrophilic functional derivatives thereof, and the curing proceeds via one or more crosslinking groups selected from the group consisting of an azide group, a diazo group, a diazide group, and a carbodiimide group.
8. A centrifugal ultrafiltration filter unit comprising the ultrafiltration membrane according to claim 1.
9. A method for separating, purifying and / or concentrating a biological material, using the centrifugal ultrafiltration filter unit according to claim 8.
10. A method for producing an ultrafiltration membrane having the ability to inhibit the adhesion of biological material, comprising the steps of applying a coating film-forming composition having the ability to inhibit the adhesion of biological material to at least a portion of the surface of the ultrafiltration membrane, and drying the applied composition.
11. The method according to claim 10, wherein the composition for forming a coating film comprises a polymer containing a repeating unit derived from one or more ethylenically unsaturated monomers selected from the group consisting of (meth)acrylic acid and its esters, vinyl acetate, vinylpyrrolidone, ethylene, vinyl alcohol, and hydrophilic functional derivatives thereof.
12. The method according to claim 11, wherein the composition for forming a coating film contains a crosslinking component containing one or more crosslinking groups selected from the group consisting of an azide group, a diazo group, a diazide group, and a carbodiimide group.
Citation Information
Patent Citations
Fouling prevention material and separation membrane having surface treated with the fouling prevention material
JP2006239636A
Method for producing porous filtration membrane for water treatment
JP2016077923A
Surface-modified porous film and production method for same
WO2017170210A1
Cited By
Biological substance adhesion-suppressing material
WO2026192010A1
